​

Sonnet BioTherapeutics Ownership | Who Owns Sonnet BioTherapeutics?

OverviewRevenueFinancialsChart

Sonnet BioTherapeutics Ownership Summary

Sonnet BioTherapeutics is owned by 0.05% institutional investors, and 99.95% retail investors. Cinvest Azero Global FI is the top mutual fund, with 0.69% of its assets in Sonnet BioTherapeutics shares.

SONN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSonnet BioTherapeutics0.05%-99.95%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20221-94.44%2,000-99.94%-0.00%--100.00%--100.00%
Jun 30, 202218-14.29%3,519,106-41.21%920.37%6-53.85%6100.00%
Mar 31, 20222131.25%5,985,79350.03%1571.43%1362.50%3200.00%
Dec 31, 20211623.08%3,989,73642.96%1051.95%833.33%1-
Sep 30, 20211330.00%2,790,790164.02%739.49%650.00%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Cinvest Azero Global FI37.50K0.69%32.81K
Vanguard Institutional Extnd Mkt Idx Tr1.84K0.27%-1.00
Fidelity Extended Market Index3.06K0.06%1.36K
Fidelity Series Total Market Index348.000.01%-
NT Ext Equity Mkt Idx Fd - L92.000.00%-
Northern Trust Extended Eq Market Idx92.000.00%-
SSgA U.S. Extended Market Index Class I72.000.00%-
State St US Extended Mkt Indx NL Cl C8.000.00%-1.00
SSgA U.S. Total Market Index Strategy30.000.00%9.00
NT Ext Eq Mkt Indx Fd DC Lending Tier 514.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 27, 2023Rao Raghu-Buy$25.00K
Oct 27, 2023Rao Raghu-Buy$50.00K
Oct 27, 2023Mohan Pankaj Chairman, President and CEOBuy$110.00K
Oct 27, 2023Mohan Pankaj Chairman, President and CEOBuy$55.00K
Jun 14, 2023Dexter Susan Chief Technical OfficerBuy$7.00K

Insider Transactions Trends

DateBuySell
2023 Q44-
2023 Q3--
2023 Q24-
2023 Q11-
2022 Q4--

SONN Ownership FAQ

Who Owns Sonnet BioTherapeutics?

Sonnet BioTherapeutics shareholders are primarily institutional investors at 0.05%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Sonnet BioTherapeutics's industry, Biotech Stocks , is 47.04%, which Sonnet BioTherapeutics falls below.

Does Blackrock own Sonnet BioTherapeutics?

BlackRock is not among the top 10 institutional shareholders of Sonnet BioTherapeutics.

Who is the top mutual fund holder of Sonnet BioTherapeutics shares?

Cinvest Azero Global FI is the top mutual fund holder of Sonnet BioTherapeutics shares, with 0.69% of its total shares outstanding invested in 37.5K Sonnet BioTherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools